These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10409443)

  • 1. Adhesion proteins in the biology of breast cancer: contribution of CD44.
    Herrera-Gayol A; Jothy S
    Exp Mol Pathol; 1999 Jun; 66(2):149-56. PubMed ID: 10409443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
    Herrera-Gayol A; Jothy S
    Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 family and gynaecological cancer.
    Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
    In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronidase can modulate expression of CD44.
    Stern R; Shuster S; Wiley TS; Formby B
    Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells.
    Lakshmi MS; Parker C; Sherbet GV
    Anticancer Res; 1997; 17(5A):3451-5. PubMed ID: 9413186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
    Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
    Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
    Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the dual nature of CD44 in breast cancer progression.
    Louderbough JM; Schroeder JA
    Mol Cancer Res; 2011 Dec; 9(12):1573-86. PubMed ID: 21970856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases.
    Gee K; Kryworuchko M; Kumar A
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.